Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153517 · ClinicalTrials.gov registry record · Phase 2
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
A Phase 2 study of Premature Birth and Birth Weight, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT00153517 is a Phase 2 study of Premature Birth and Birth Weight that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 126 participants, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00153517, a Phase 2 study of Premature Birth and Birth Weight, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and intravaginal metronidazole for the treatment of BV 3. To study the efficacy of oral and intravaginal metronidazole for the prevention of hospital admission during the 3rd trimester, chorioamnionitis, preterm delivery, and maternal infectious morbidity.
Conditions Studied
Interventions
- DRUG oral versus vaginal metronidazole
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 1999-10 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00153517
The ClinicalTrials.gov registry entry for NCT00153517 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (68% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which oral versus vaginal metronidazole is the first listed.
NCT00153517 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00153517 about?
NCT00153517 is a clinical study titled "Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy". The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and int...
What is the current status of trial NCT00153517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 1999-10. Estimated completion is 2004-09.
What conditions does trial NCT00153517 study?
This clinical trial studies the following conditions: Premature Birth, Birth Weight, Chorioamnionitis, Vaginosis, Bacterial.
What interventions are being tested in trial NCT00153517?
The interventions under investigation include: oral versus vaginal metronidazole (DRUG).
Who is sponsoring clinical trial NCT00153517?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00153517 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
COMPLETED · Phase 2
-
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
RECRUITING · Phase 4
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.